Cargando…
Lipid levels and major adverse cardiovascular events in patients initiated on statins for primary prevention: an international population-based cohort study protocol
BACKGROUND: Clinical guidelines recommend specific targets for low-density lipoprotein cholesterol (LDL-C) and non-high-density lipoprotein cholesterol (non-HDL-C) for primary prevention of cardiovascular disease (CVD). Furthermore, individual variability in lipid response to statin therapy requires...
Autores principales: | Blais, Joseph E, Akyea, Ralph Kwame, Coetzee, Annelize, Chan, Amy HY, Lau, Wallis CY, Man, Kenneth KC, Harrison, Jeff, Chan, Esther W, Beyene, Kebede A, Wong, Ian CK, Weng, Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal College of General Practitioners
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960514/ https://www.ncbi.nlm.nih.gov/pubmed/33172851 http://dx.doi.org/10.3399/bjgpopen20X101127 |
Ejemplares similares
-
Determining propensity for sub-optimal low-density lipoprotein cholesterol response to statins and future risk of cardiovascular disease
por: Weng, Stephen Franklin, et al.
Publicado: (2021) -
Sub-optimal cholesterol response to initiation of statins and future risk of cardiovascular disease
por: Akyea, Ralph Kwame, et al.
Publicado: (2019) -
Efficacy and safety of tofacitinib in the treatment of rheumatoid arthritis: a systematic review and meta-analysis
por: He, Ying, et al.
Publicado: (2013) -
Impact of the COVID‐19 pandemic on use of anti‐dementia medications in 34 European and North American countries
por: Ju, Chengsheng, et al.
Publicado: (2021) -
Statin treatment and LDL-cholesterol treatment goal attainment among individuals with familial hypercholesterolaemia in primary care
por: Iyen, Barbara, et al.
Publicado: (2021)